Brilinta

(ticagrelor)
BRILINTA (ticagrelor) 60 MG Oral TabletBRILINTA (ticagrelor) 90 MG Oral Tablet

Dosage & administration

Use BRILINTA with a daily maintenance dose of aspirin of 75-100 mg. (2, 5.2)

drug label

Brilinta prescribing information

samples

Request Brilinta samples

Online Sample Form
Learn More

financial assistance

Brilinta financial assistance options

Co-pay savings program

commercial only

OTHER
Enroll in Patient Savings Program
Learn More

patient education

Brilinta patient education

Getting started on Brilinta

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

BRAND PAGE
About Brilinta: ACS or Prior MI
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
View How to Take Brilinta: ACS or Prior MI
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGE
Side Effects: ACS or Prior MI
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGE
About Brilinta: High-risk CAD Without History of MI or Stroke
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGE
About Brilinta: Acute Ischemic Stroke or High-risk TIA
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Doctor Discussion Guide: ACS or Prior MI
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Patient Brochure: ACS or Prior MI
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Medicine Planner
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

Other resources

Learn More

people also ask

Brilinta FAQs

How is the dosage of Brilinta?Brilinta is available in 2 dosages, including 60 mg Tab and 90 mg Tab
What does Brilinta treat?Brilinta treats
What is Brilinta made of?Brilinta contains ticagrelor which is a P2Y12 Platelet Inhibitor
How Is Brilinta Administered?Brilinta is administered as a Oral Pill
What Are The Brilinta Mechanism Of Action?Brilinta mechanism of action is Cytochrome P450 3A4 Inhibitors, Cytochrome P450 3A5 Inhibitors, P-Glycoprotein Inhibitors, P2Y12 Receptor Antagonists or Phenylalanine Hydroxylase Activators
FAQ Data Source